These comorbid conditions include hypertension (high blood pressure), Type 2 diabetes, or dyslipidemia
Initial approval rates for obesity medications sit around 35-40% across major Canadian insurers
Heres what you need to know: Concentration Matters The concentration is typically listed as something like 10mg/mL
Use of blood pressure and lipid-lowering medication, as well as prior and current tobacco use, is reported in Supplementary Table 5
Without insurance, Wegovy lists at approximately $1,349 per month as of 2026, while compounded versions from reputable pharmacies range from $199 to $399 per month depending on dose and provider
In terms of reduction in glucose levels at 2 h after OGTT, 5 studies (with 205 and 213 subjects the experimental and control groups, respectively) were included for analysis